NM_000540.3:c.9623C>T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PP2PP3_ModeratePP5
The NM_000540.3(RYR1):c.9623C>T(p.Pro3208Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000771 in 1,556,552 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000540.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000783 AC: 11AN: 1404350Hom.: 0 Cov.: 31 AF XY: 0.0000130 AC XY: 9AN XY: 693132
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74360
ClinVar
Submissions by phenotype
RYR1-related disorder Pathogenic:2
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 3208 of the RYR1 protein (p.Pro3208Leu). This variant is present in population databases (rs758210285, gnomAD 0.005%). This missense change has been observed in individual(s) with clinical features of autosomal recessive RYR1-related myopathy (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 586415). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
The RYR1 c.9623C>T variant is predicted to result in the amino acid substitution p.Pro3208Leu. This variant has been reported in the compound heterozygous state in two patients affected with congenital myopathy (Kalfon et al. 2022. PubMed ID: 34970863; Chang et al. 2022. PubMed ID: 35693006). Additionally, we have observed this variant alongside a second plausible causative variant in the RYR1 gene in other patients at PreventionGenetics affected with congenital myopathy. This variant is reported in 0.0052% of alleles in individuals of European (Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-39006795-C-T). This variant is interpreted as likely pathogenic. -
not provided Pathogenic:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34970863, 35693006, 12668474) -
The frequency of this variant in the general population is consistent with pathogenicity. (http://gnomad.broadinstitute.org) This variant has been identified in at least one individual with congenital myopathy and segregates with disease in multiple families. Polyphen and MutationTaster predict this amino acid change may be damaging to the protein. -
RYR1-related myopathy Pathogenic:1
- -
Malignant hyperthermia, susceptibility to, 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at